BR122019018448B8 - método para extração de succinilacetona e um ou mais analitos biológicos adicionais - Google Patents

método para extração de succinilacetona e um ou mais analitos biológicos adicionais

Info

Publication number
BR122019018448B8
BR122019018448B8 BR122019018448A BR122019018448A BR122019018448B8 BR 122019018448 B8 BR122019018448 B8 BR 122019018448B8 BR 122019018448 A BR122019018448 A BR 122019018448A BR 122019018448 A BR122019018448 A BR 122019018448A BR 122019018448 B8 BR122019018448 B8 BR 122019018448B8
Authority
BR
Brazil
Prior art keywords
succinylacetone
additional biological
biological analytes
sample
mass spectrometry
Prior art date
Application number
BR122019018448A
Other languages
English (en)
Other versions
BR122019018448B1 (pt
Inventor
Cherkasskiy Alex
Cerda Blas
La Marca Giancarlo
Li Yijun
Original Assignee
Azienda Ospedaliero Univ Meyer Di Firenze
Perkinelmer Health Sci Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39939802&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR122019018448(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Azienda Ospedaliero Univ Meyer Di Firenze, Perkinelmer Health Sci Inc filed Critical Azienda Ospedaliero Univ Meyer Di Firenze
Publication of BR122019018448B1 publication Critical patent/BR122019018448B1/pt
Publication of BR122019018448B8 publication Critical patent/BR122019018448B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Luminescent Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

a presente invenção refere-se, entre outras coisas, à detecção e/ou medição de succinilacetona e um ou mais analitos biológicos adicionais usando espectrometria de massa.
BR122019018448A 2007-05-04 2008-05-05 método para extração de succinilacetona e um ou mais analitos biológicos adicionais BR122019018448B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11/744,789 US7951608B2 (en) 2007-05-04 2007-05-04 Detecting succinylacetone
US11/744,789 2007-05-04
PCT/US2008/062694 WO2008137868A1 (en) 2007-05-04 2008-05-05 Detecting succinylacetone
BRPI0811536A BRPI0811536B8 (pt) 2007-05-04 2008-05-05 método para detectar uma cetona biologicamente ativa e método para extração
PI0811536-2 2008-05-05

Publications (2)

Publication Number Publication Date
BR122019018448B1 BR122019018448B1 (pt) 2020-06-30
BR122019018448B8 true BR122019018448B8 (pt) 2021-07-27

Family

ID=39939802

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0811536A BRPI0811536B8 (pt) 2007-05-04 2008-05-05 método para detectar uma cetona biologicamente ativa e método para extração
BR122019018448A BR122019018448B8 (pt) 2007-05-04 2008-05-05 método para extração de succinilacetona e um ou mais analitos biológicos adicionais

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0811536A BRPI0811536B8 (pt) 2007-05-04 2008-05-05 método para detectar uma cetona biologicamente ativa e método para extração

Country Status (10)

Country Link
US (3) US7951608B2 (pt)
EP (1) EP2155185B2 (pt)
CN (1) CN101742995B (pt)
AT (1) ATE551055T1 (pt)
AU (1) AU2008247428C1 (pt)
BR (2) BRPI0811536B8 (pt)
CA (1) CA2686202C (pt)
DK (1) DK2155185T4 (pt)
ES (1) ES2384288T5 (pt)
WO (1) WO2008137868A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100227412A1 (en) * 2009-02-06 2010-09-09 Perkinelmer Health Sciences, Inc. Simultaneous Detection of Estrogen and Non Estrogen Steroids
GB201215924D0 (en) * 2012-09-06 2012-10-24 Univ Swansea Kit and method for quantitative detection of steroids
EP2926139B1 (en) * 2012-12-03 2018-07-11 Statens Serum Institut Method of diagnosing galactosemia in neonatal screening
ES2705574T3 (es) 2013-10-22 2019-03-26 Hoffmann La Roche Procedimientos para medir partículas de virus libres de células a partir de gotas de sangre seca
CN105572233A (zh) * 2014-11-18 2016-05-11 湖南农业大学 植物叶片中琥珀酰丙酮的检测方法
WO2018174858A1 (en) * 2017-03-21 2018-09-27 Mprobe Inc. Clinical method for the population screening of adult metabolic disorder associated with chronic human disease
CN108008031A (zh) * 2017-11-17 2018-05-08 深圳华大生命科学研究院 同时检测氨基酸、肉碱、酮类、激素的方法和试剂盒
CN108051494A (zh) * 2017-11-17 2018-05-18 深圳华大生命科学研究院 一种同时检测多种遗传代谢疾病相关物质的方法和试剂盒
CN110568088A (zh) * 2019-05-22 2019-12-13 广州金域医学检验中心有限公司 琥珀酰丙酮的检测方法
CN113030326B (zh) * 2021-03-12 2023-03-10 杭州度安医学检验实验室有限公司 一种用于分离柠檬酸和异柠檬酸的衍生试剂盒和方法
US20220395767A1 (en) * 2021-06-15 2022-12-15 Perkinelmer Health Sciences, Inc. Enhancing lcms analyte signals
CN114965786B (zh) * 2022-06-07 2023-11-03 重庆医科大学附属儿童医院 一种检测干血斑中酯类胆固醇多种中间代谢产物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE515702T1 (de) * 2003-01-30 2011-07-15 Life Technologies Corp Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung
WO2005048926A2 (en) * 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
US20070004045A1 (en) * 2005-06-07 2007-01-04 Xia Xu Analysis of large numbers of estrogens and other steroids and applications thereof

Also Published As

Publication number Publication date
ATE551055T1 (de) 2012-04-15
BRPI0811536B1 (pt) 2020-08-11
US20080274563A1 (en) 2008-11-06
US8513025B2 (en) 2013-08-20
AU2008247428B2 (en) 2014-07-03
BRPI0811536A8 (pt) 2019-10-15
BRPI0811536A2 (pt) 2014-11-18
CA2686202C (en) 2017-07-04
EP2155185A4 (en) 2010-11-24
ES2384288T5 (es) 2022-05-26
AU2008247428A1 (en) 2008-11-13
CA2686202A1 (en) 2008-11-13
DK2155185T3 (da) 2012-07-16
EP2155185A1 (en) 2010-02-24
DK2155185T4 (da) 2022-02-07
EP2155185B1 (en) 2012-03-28
CN101742995B (zh) 2013-08-14
WO2008137868A1 (en) 2008-11-13
BR122019018448B1 (pt) 2020-06-30
US20110201539A1 (en) 2011-08-18
US8278116B2 (en) 2012-10-02
ES2384288T3 (es) 2012-07-03
EP2155185B2 (en) 2021-12-01
CN101742995A (zh) 2010-06-16
AU2008247428C1 (en) 2015-01-29
US7951608B2 (en) 2011-05-31
US20120309096A1 (en) 2012-12-06
BRPI0811536B8 (pt) 2021-07-27

Similar Documents

Publication Publication Date Title
BR122019018448B8 (pt) método para extração de succinilacetona e um ou mais analitos biológicos adicionais
IN2014DN02241A (pt)
WO2010099108A3 (en) Multiplexing derivatized anayltes using mass spectroscopy
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
EP4249605A3 (en) Methods for analyte detection
MY170164A (en) Aptamer-based multiplexed assays
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
WO2014066117A3 (en) Neutron encoded mass tags for analyte quantification
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
BRPI0911863A2 (pt) método para determinar a presença de um analito em uma amostra de estrutura queratinizada de um indivíduo.
WO2011088014A3 (en) Systems and methods for counting cells and biomolecules
BRPI0605166A (pt) método de determinação de ácido metilmalÈnico baseado na extração alquilativa associada à cromatografia lìquida acoplada à espectrometria de massas
WO2009103843A3 (en) Method and device for detection of an analyte
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
MX2009010751A (es) Composiciones y metodos de deteccion.
DK1989544T3 (da) T-celle-testmetode
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
EP1898215A4 (en) METHOD FOR ANALYZING ENDOCRINE SUBSTANCE IN A SPECIMEN
ES2684758T3 (es) Procedimiento para diagnosticar fibrosis hepática
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул
WO2011088423A3 (en) Isobaric tags for analyte detection and quantification
GB201119585D0 (en) Assay
EP2549270A3 (en) Biosensor desiccant system having enhanced measurement performance
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
UA93082U (uk) Точний та малобюджетний інтегрований електродний чип для цільового аналізу

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/06/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/05/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B22B Petition not considered [chapter 22.2 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 870210088845, DE 27/09/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI